ASN
TARS icon

Advisory Services Network’s Tarsus Pharmaceuticals TARS Stock Holding History

Advisory Services Network’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-190
Closed -$13.3K – 4353
2026
Q1 		$13.3K Buy
+190
New +$13.3K ﹤0.01% 3410
2025
Q1 		– Sell
-60,459
Closed -$3.35M – 1727
2024
Q4 		$3.35M Buy
60,459
+22,648
+60% +$1.03M 0.06% 341
2024
Q3 		$1.03M Hold
37,811
– – 0.02% 705
2024
Q2 		$1.03M Buy
+37,811
New +$1.27M 0.02% 705

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Advisory Services Network's TARS Position: Q2 2026 in Review

Advisory Services Network sold out of Tarsus Pharmaceuticals (TARS) in Q2 2026, closing a stake of 190 shares — an estimated $13.3K sold.

Advisory Services Network first reported a position in TARS in Q2 2024 and held it in 4 quarters. The position peaked at $3.35M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Advisory Services Network reported no remaining Tarsus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 190 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $13.3K.
  • Advisory Services Network first reported a position in Tarsus Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Advisory Services Network's Tarsus Pharmaceuticals position peaked at $3.35M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.